Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Head Injury
BrainBox secures $3.5M NINDS grant
By
LabPulse.com staff writers
The company will use the funding to develop a test system for mild traumatic brain injury in elderly patients. In addition, it will collaborate with the Virginia Tech Carilion School of Medicine in Roanoke, VA, on a trial called the HeadSmart Geriatrics Study. The test will integrate blood biomarkers and functional tests.
March 20, 2022
Abbott wins FDA nod for blood test to diagnose concussion
By
LabPulse.com staff writers
The test identifies and measures specific proteins that are present in the blood after a traumatic brain injury. Clinicians can use the diagnostic to confirm or rule out the need for CT scans, according to Abbott.
January 10, 2021
AI market on the rise | Pathology makeover wanted | A closer look at traumatic brain injury
By
Emily Hayes
Dear LabPulse Member,
October 14, 2019
Pathology study challenges conventional wisdom on brain injury
By
Emily Hayes
The prospective Traumatic Head Injury Neuroimaging Classification (THINC) study was funded by the U.S. Department of Defense and the National Institute of Neurological Disorders and Stroke (NINDS).
October 14, 2019
BrainBox concussion test wins breakthrough status
By
LabPulse.com staff writers
The company's BrainBox TBI product includes a panel test for blood protein biomarkers that could be indicators of traumatic brain injury (TBI), including glial fibrillary acidic protein, neuron-specific enolase, and neurogranin. BrainBox TBI evaluates neurological features to make an overall assessment in a single score for mild TBI, or concussion.
June 6, 2019
Page 1 of 1